The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Bogolepova A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Poststroke motor and cognitive impairments: clinical features and current approaches to rehabilitation

Authors:

Levin O.S., Bogolepova A.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(11): 99‑107

DOI: 10.17116/jnevro202012011199

Read: 58440 times

Download PDF (RU)
Contact the author
Table of contents

POSTSTROKE MOTOR AND COGNITIVE IMPAIRMENTS: CLINICAL FEATURES AND CURRENT APPROACHES TO REHABILITATION
POSTSTROKE MOTOR AND COGNITIVE IMPAIRMENTS: CLINICAL FEATURES AND CURRENT APPROACHES TO REHABILITATION

To cite this article:

Levin OS, Bogolepova AN. Poststroke motor and cognitive impairments: clinical features and current approaches to rehabilitation. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(11):99‑107. (In Russ.)
https://doi.org/10.17116/jnevro202012011199

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The effe­ctiveness of drug therapy in the reha­bilitation of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):132-139
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Effi­ciency of complex medi­cal reha­bilitation after pulmonary enda­rterectomy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):629-636
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
Lapa­roscopic appe­ndectomy for appe­ndiceal muco­cele in a patient with COVID-19. Endo­scopic Surgery. 2024;(6):41-45
Sano­genetic commonality of ultraviolet irra­diation of blood and intravenous ozone therapy. Choice of the opti­mal method of this impact for reha­bilitation of patients after nephrolitholapaxy. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):95-99
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
Orga­nizational issues of reproductive health protection of adolescent girls in the system of the Fede­ral Medi­cal and Biological Agency of Russia. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):7-13
Physical medi­cal reha­bilitation of patients with dystrophinopathies: dyna­mics of the disease’s course considering clinical anthropometric indi­cators. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):31-39
Influence of inte­rmittent pneumatic compression on microvasculature condition in lymphedema. Prospective randomized clinical trial. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):48-53
Abstract:

Stroke is one of the most common neurological diseases with high morbidity, disability and mortality, which is an urgent medical and social problem. Clinically, stroke, depending on its nature and location, causes a wide range of neurological disorders, including movement disorders, as well as a variety of cognitive and neuropsychiatric disorders. There is an emerging need for new approaches to manage patients with cerebrovascular diseases during the pandemic of COVID-19. Rehabilitation measures for the correction of motor and cognitive impairments are very diverse. The use of drugs stimulating the production of neurotrophic factors is considered as a promising direction of pharmacotherapy. Cerebrolysin promotes significant regression of motor and cognitive impairments in the acute and recovery period of ischemic stroke. Based on the data of clinical studies, Cerebrolysin is included in the guidelines for the rehabilitation of patients with stroke in Canada and Germany.

Keywords:

ischemic stroke
post-stroke motor impairment
post-stroke cognitive impairment
COVID-19
rehabilitation
neurotrophic drugs
cerebrolysin

Authors:

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Bogolepova A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Received:

16.11.2020

Accepted:

22.11.2020

Close metadata

References:

  1. Damulin IV. Post-Stroke Motor Disorders. Consilium medicum. 2002;5(2):64-70. (In Russ.).
  2. Kadykov AS, Shakhparonova NV. Rehabilitation After Stroke. RMZh. 2003;11(25):1390-1394. (In Russ.).
  3. Maeshima S, Truman G, Smith DS, Dohi N, Nakai K, Itakura T, Komai N. Is unilateral spatial neglect a single phenomenon? J Neurol. 1997;244(7):412-417.  https://doi.org/10.1007/s004150050114
  4. Classen J, Schnitzler A, Binkofski F, Werhahn KJ, Kim YS, Kessler KR, Benecke R. The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemiparetic. Brain. 1997;120(Pt 4):605-619.  https://doi.org/10.1093/brain/120.4.605
  5. Kollen B, van de Port I, Lindeman E, Twisk J, Kwakkel G. Predicting improvement in gait after stroke: a longitudinal prospective study. Stroke. 2005;36(12):2676-2680. https://doi.org/10.1161/01.STR.0000190839.29234.50
  6. Haggard P, Cockburn J, Cock J, Fordham C, Wade D. Interference between gait and cognitive tasks in a rehabilitating neurological population. J Neurol Neurosurg Psychiatry. 2000;69(4):479-486.  https://doi.org/10.1136/jnnp.69.4.479
  7. Ghika-Schmid F, Ghika J, Regli F, Bogousslavsky J. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci. 1997;146(2):109-116.  https://doi.org/10.1016/s0022-510x(96)00290-0
  8. Posteraro L, Formis A, Grassi E, Bighi M, Nati P, Proietti Bocchini C, Todeschini E, Bidini C, Corsini D, Agosti M, Franceschini M. Quality of life and aphasia. Multicentric standardization of a questionnaire. Eura Medicophys. 2006;42:227-230. 
  9. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, PA: Lea & Febiger; 1983.
  10. Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862(5):915-925.  https://doi.org/10.1016/j.bbadis.2016.01.015
  11. Jokinen H, Melkas S, Ylikoski R, Pohjasvaara T, Kaste M, Erkinjuntti T, Hietanen M. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288-1294. https://doi.org/10.1111/ene.12743
  12. Jacquin A, Binquet C, Rouaud O, Graule-Petot A, Daubail B, Osseby GV, Bonithon-Kopp C, Giroud M, Béjot Y. Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke. J Alzheimers Dis. 2014;40(4):1029-1038. https://doi.org/10.3233/JAD-131580
  13. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke: the Framingham Study. Stroke. 2004;35(6):1264-1268. https://doi.org/10.1161/01.STR.0000127810.92616.78
  14. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Herrmann F, Moulias R, Hauw JJ. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging. 2003;24(2):213-219.  https://doi.org/10.1016/s0197-4580(02)00066-0
  15. Firbank MJ, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C, Kalaria RN, O’Brien JT. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging. 2007;28(11):1664-1669. https://doi.org/10.1016/j.neurobiolaging.2006.07.009
  16. Gemmell E, Bosomworth H, Allan L, Hall R, Khundakar A, Oakley AE, Deramecourt V, Polvikoski TM, O’Brien JT, Kalaria RN. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke. 2012;43(3):808-814.  https://doi.org/10.1161/STROKEAHA.111.636498
  17. Qiu C, Zhang Y, Bronge L, Herlitz A, Aspelin P, Bäckman L, Fratiglioni L, Wahlund LO. Medial temporal lobe is vulnerable to vascular risk factors in men: a population-based study. Eur J Neurol. 2012;19(6):876-883.  https://doi.org/10.1111/j.1468-1331.2011.03645.x
  18. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689-701.  https://doi.org/10.1016/S1474-4422(10)70104-6
  19. Macfarlane MD, Looi JC, Walterfang M, Spulber G, Velakoulis D, Crisby M, Orndahl E, Erkinjuntti T, Garde E, Waldemar G, Wallin A, Wahlund LO; LADIS Study Group. Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS. Psychiatry Res. 2013;214(1):16-23.  https://doi.org/10.1016/j.pscychresns.2013.05.010
  20. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O’Brien J, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T; LADIS group. 20. Longitudinal cognitive decline in subcortical ischemic vascular disease — the LADIS Study. Cerebrovasc Dis. 2009;27(4):384-391.  https://doi.org/10.1159/000207442
  21. Kooistra M, Geerlings MI, van der Graaf Y, Mali WP, Vincken KL, Kappelle LJ, Muller M, Biessels GJ; SMART-MR Study Group. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study. Neurobiol Aging. 2014;35(1):35-41.  https://doi.org/10.1016/j.neurobiolaging.2013.07.004
  22. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007;130(Pt 8):1988-2003. https://doi.org/10.1093/brain/awl387
  23. Gregoire SM, Smith K, Jäger HR, Benjamin M, Kallis C, Brown MM, Cipolotti L, Werring DJ. Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovasc Dis. 2012;33(5):430-435.  https://doi.org/10.1159/000336237
  24. Qiu C, Cotch MF, Sigurdsson S, Jonsson PV, Jonsdottir MK, Sveinbjrnsdottir S, Eiriksdottir G, Klein R, Harris TB, van Buchem MA, Gudnason V, Launer LJ. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology. 2010;75(24):2221-2228. https://doi.org/10.1212/WNL.0b013e3182020349
  25. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, Breteler MM, Vernooij MW. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012;78(5):326-333.  https://doi.org/10.1212/WNL.0b013e3182452928
  26. Jellinger KA. The enigma of mixed dementia. Alzheimers Dement. 2007;3(1):40-53.  https://doi.org/10.1016/j.jalz.2006.09.002
  27. Desmond DW, Moroney JT, Paik MC, Sano M, Mohr JP, Aboumatar S, Tseng CL, Chan S, Williams JB, Remien RH, Hauser WA, Stern Y. Frequency and clinical determinants of dementia after ischemic stroke. Neurology. 2000;54(5):1124-1131. https://doi.org/10.1212/wnl.54.5.1124
  28. Tang EY, Amiesimaka O, Harrison SL, Green E, Price C, Robinson L, Siervo M, Stephan BC. Longitudinal Effect of Stroke on Cognition: A Systematic Review. J Am Heart Assoc. 2018;7(2):e006443. https://doi.org/10.1161/JAHA.117.006443
  29. Sibolt G, Curtze S, Melkas S, Putaala J, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Erkinjuntti T. Poststroke dementia is associated with recurrent ischaemic stroke. J Neurol Neurosurg Psychiatry. 2013;84(7):722-726.  https://doi.org/10.1136/jnnp-2012-304084
  30. Wilcox ME, Brummel NE, Archer K, Ely EW, Jackson JC, Hopkins RO. Cognitive dysfunction in ICU patients: risk factors, predictors, and rehabilitation interventions. Crit Care Med. 2013;41(9 suppl 1):81-98.  https://doi.org/10.1097/CCM.0b013e3182a16946
  31. Needham DM, Dinglas VD, Bienvenu OJ, Colantuoni E, Wozniak AW, Rice TW, Hopkins RO; NIH NHLBI ARDS Network. One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial. BMJ. 2013;346:f1532. https://doi.org/10.1136/bmj.f1532
  32. Gusev EI, Martynov MYu, Boyko AN, Voznyuk IA, Lasch NYu, Sivertseva SA, Spirin NN, Shamalov NA. New coronavirus infection (COVID-19) and nervous system damage: mechanisms of neurological disorders, clinical manifestations, organization of neurological care. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020;120(6):7-16. (In Russ.). https://doi.org/10.17116/jnevro20201200617
  33. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147.  https://doi.org/10.1016/j.thromres.2020.04.013
  34. Baker HA, Safavynia SA, Evered LA. The «Third Wave»: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth. 2020. [Epub ahead of print] https://doi.org/10.1016/j.bja.2020.09.045
  35. Corea F, Scarponi F, Zampolini M. Upper limb function as an outcome predictor in acute stroke. Stroke. 2010;41:e466-468. 
  36. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, Pessin MS, Bleich HL. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology. 1978;28(8):754-762.  https://doi.org/10.1212/wnl.28.8.754
  37. Silvestrelli G, Corea F, Paciaroni M, Milia P, Palmerini F, Parnetti L, Gallai V. The Perugia Hospital- Based Stroke Registry: report of the second year. Clin Exp Hypertens. 2002;24(7-8):485-491.  https://doi.org/10.1081/ceh-120015324
  38. Paciaroni M, Caso V, Milia P, Venti M, Silvestrelli G, Palmerini F, Nardi K, Micheli S, Agnelli G. Isolated monoparesis following stroke. J Neurol Neurosurg Psychiatry. 2005;76(6):805-807.  https://doi.org/10.1136/jnnp.2004.047779
  39. Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res. 1981;4:483-492.  https://doi.org/10.1097/00004356-198112000-00001
  40. Bogolepova AN, Levin OS. Cognitive rehabilitation of patients with focal brain damage. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020;120(4):115-122. (In Russ.). https://doi.org/10.17116/jnevro2020120041115
  41. Carmichael ST. Plasticity of cortical projections after stroke. Neuroscientist. 2003;9(1):64-75.  https://doi.org/10.1177/1073858402239592
  42. Stroemer RP, Kent TA, Hulsebosch CE. Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke. 1995;26(11):2135-2144. https://doi.org/10.1161/01.str.26.11.2135
  43. Levin OS, Chimagemedova ASh. Post-Stroke Motor Impairment. Modern Therapy Psychiatry Neurology. 2017;3:27-33. (In Russ.).
  44. Masliah E, Díez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today (Barc). 2012;48(suppl A):3-24.  https://doi.org/10.1358/dot.2012.48(Suppl.A).1739716
  45. Muresanu DF, Heiss WD, Hoemberg V, Bajenaru O, Popescu CD, Vester JC, Rahlfs VW, Doppler E, Meier D, Moessler H, Guekht A. Cerebrolysin and Recovery After Stroke (CARS). A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016;47.  https://doi.org/10.1161/STROKEAHA.115.009416
  46. Hartbauer M, Hutter-Paie B, Windisch M. Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons. J Neural Transm (Vienna). 2001;108(5):581-592. 
  47. Akai F, Hiruma S, Sato T, Iwamoto N, Fujimoto M, Ioku M, Hashimoto S. Neurotrophic factor-like effect of FPFlO7O on Septal cholinergic neurons after transections of fimbria-fornix in the rat brain. Histol Histopathol. 1992;7(2):21-21. 
  48. Ladurner G, Kalvach P, Moessler H; Cerebrolysin Study Group. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. J Neural Transm (Vienna). 2005;112(3):415-428.  https://doi.org/10.1007/s00702-004-0248-2
  49. Vilensky BS, Kuznetsov LN, Vinogradov OI. Repeated course administration of Cerebrolysin — a new direction of rehabilitation of patients who have suffered an ischemic stroke. RMZh. 2008;16(12):2-4. (In Russ.).
  50. Bornstein NM, Guekht A, Vester J, Heiss W-D, Gusev E, Hömberg V, Rahlfs VW, Bajenaru O, Popescu BO, Muresanu D. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurological Sciences. 2018;39:629-640.  https://doi.org/10.1007/s10072-017-3214-0
  51. Bogolepova AN. Possibilities of neurotrophic therapy in early recovery after stroke. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2019;119(8 issue 2):74-79. (In Russ.). https://doi.org/10.17116/jnevro201911908274
  52. Teasell R, Iruthayarajah J, Saikaley M, Longval M. Evidence based review of stroke rehabilitation (EBRSR) 19th Edition. 2019; 209. Accessed November 19, 2020. https://www.ebrsr.com/sites/default/files/chapter%2010_version%2019.pdf
  53. Teasell R, Norhayati H, Mirkowski M, Vanderlaan D, Saikaley M, Longval M, Iruthayarajah J. Stroke Rehabilitation Clinician Handbook. 2020;44. Accessed November 19, 2020. https://www.ebrsr.com/sites/default/files/EBRSR%20Handbook%20Chapter%204_Upper%20Extremity%20Post%20Stroke_ML.pdf
  54. Association of the Scientific Medical Societies in Germany. Rehabilitative Therapie bei Armparese nach Schlaganfall. der DGNR — Langversion. 2020;204. Accessed November 19, 2020. https://www.awmf.org/uploads/tx_szleitlinien/080-001l_S3_Rehabilitative_Therapie_bei_Armparese_nach_Schlaganfall_2020-07.pdf
  55. Guekht AB, Moessler H, Novak PH, Gusev EI; Cerebrolysin Investigators. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. J Stroke Cerebrovasc Dis. 2011;20(4):310-318.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.01.012
  56. Cui S, Chen N, Yang M, Guo J, Zhou M, Zhu C, He L. Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2019;2019(11):CD008900. https://doi.org/10.1002/14651858.CD008900.pub3
  57. Ruether E, Husmann R, Kinzler E, Diabl E, Klingler D, Spatt J, Ritter R, Schmidt R, Taneri Z, Winterer W, Koper D, Kasper S, Rainer M, Moessler H.A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer’s disease. Int Clin Psychopharmacol. 2001;16(5):253-263.  https://doi.org/10.1097/00004850-200109000-00002
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.